Novel Ce(III)-Metal Organic Framework with a Luminescent Property To Fabricate an Electrochemiluminescence Immunosensor
Source abstract
Abstract
We designed a novel luminescent metal–organic framework (MOF) named Ce-TCPP-LMOF (CTM) through a simple one-pot solvothermal method. CTM was synthesized by using the emerging electrochemiluminescent (ECL) material (4,4′,4″,4‴-(porphine-5,10,15,20-tetrayl)tetrakis(benzoic acid) as the organic ligand and Ce(III) as the metal node. We found that CTM not only has the remarkable ability to emit light but also has a uniform “sandwich biscuit” shape and suitable nanoscale size, which are promising for further applications. We also applied CTM to construct a novel ECL immunosensor and achieve sensitive detection of the proprotein convertase subtilisin/kexin type 9 (PCSK9), a biomarker related to cardiovascular diseases. To further amplify the ECL signal of CTM, a novel dual-amplified signal strategy was established by inducing a polyamidoamine dendrimer (PAMAM) and gold nanoparticles (AuNPs). Importantly, we first proved that the ECL signal of the CTM/S2O82– system could be enhanced by the PAMAM electric field. As the electron transfer rate was accelerated by the AuNP layer, this ECL signal was further enhanced in AuNP-modified electrodes. The ECL immunosensor showed desirable performance for PCSK9 analysis within a detection range of 50 fg mL–1 to 10 ng mL–1 and a low limit of detection of 19.12 ± 2.69 fg mL–1. Real sample detection suggested that the immunosensor holds great potential for analyzing clinical serum samples.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Advanced Nanomaterials in Catalysis · Biosensors and Analytical Detection
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
The First People’s Hospital of Zigong, Zigong, Sichuan 643000, PR China
University-Town Hospital of Chongqing Medical University, Chongqing 400016, P. R. China
Funding
Chongqing Medical University · National Natural Science Foundation of China · Chongqing foundation and advanced research project · Chongqing precision medical key technology research and development and demonstration projects
References (57)
Show source-provided references
1. 10.1039/C5CS00086F10.1039/C5CS00086F ↗
2. Saltelli A. · 2000 · 1
3. Müller-Buschbaum K. · 2015 · 7
4. 10.1039/C7CS90049J10.1039/C7CS90049J ↗
5. 10.1016/j.talanta.2017.12.01210.1016/j.talanta.2017.12.012 ↗
6. 10.1016/j.talanta.2019.01.08610.1016/j.talanta.2019.01.086 ↗
7. 10.1039/C8AN00909K10.1039/C8AN00909K ↗
8. 10.1039/C8DT03050B10.1039/C8DT03050B ↗
9. 10.1039/C9DT00217K10.1039/C9DT00217K ↗
10. 10.1039/C7SC04528J10.1039/C7SC04528J ↗
11. 10.1002/chem.20180316110.1002/chem.201803161 ↗
12. 10.1021/acsami.8b1917210.1021/acsami.8b19172 ↗
13. 10.1002/chem.20150090910.1002/chem.201500909 ↗
14. 10.1016/j.bios.2014.12.03110.1016/j.bios.2014.12.031 ↗
15. 10.1021/acsami.8b0503810.1021/acsami.8b05038 ↗
16. 10.1016/j.snb.2018.06.09010.1016/j.snb.2018.06.090 ↗
17. 10.1016/j.bios.2016.12.06910.1016/j.bios.2016.12.069 ↗
18. 10.1016/j.bios.2019.02.05410.1016/j.bios.2019.02.054 ↗
19. 10.1002/cctc.20160095610.1002/cctc.201600956 ↗
20. 10.1016/j.ijhydene.2017.02.08810.1016/j.ijhydene.2017.02.088 ↗
21. 10.1039/c7ra12789h10.1039/c7ra12789h ↗
22. 10.1039/c4cc10346g10.1039/c4cc10346g ↗
23. 10.1038/s41598-017-06858-w10.1038/s41598-017-06858-w ↗
24. 10.1039/c7cc08200b10.1039/c7cc08200b ↗
25. 10.1021/acs.cgd.6b0151210.1021/acs.cgd.6b01512 ↗
26. 10.1016/j.bios.2017.01.06610.1016/j.bios.2017.01.066 ↗
27. 10.1001/jama.290.7.94710.1001/jama.290.7.947 ↗
28. 10.1016/j.pharmthera.2005.10.01210.1016/j.pharmthera.2005.10.012 ↗
29. 10.2174/157016104338546610.2174/1570161043385466 ↗
30. 10.1016/j.atherosclerosis.2010.09.02710.1016/j.atherosclerosis.2010.09.027 ↗
31. 10.1016/j.jjcc.2017.07.00210.1016/j.jjcc.2017.07.002 ↗
32. 10.1016/j.bios.2017.09.04310.1016/j.bios.2017.09.043 ↗
33. 10.1016/j.jchromb.2016.12.04010.1016/j.jchromb.2016.12.040 ↗
34. 10.1016/j.electacta.2014.11.00410.1016/j.electacta.2014.11.004 ↗
35. 10.1016/j.talanta.2015.11.02210.1016/j.talanta.2015.11.022 ↗
36. 10.1021/ic301239x10.1021/ic301239x ↗
37. 10.1016/j.talanta.2017.03.01610.1016/j.talanta.2017.03.016 ↗
38. 10.1016/j.bios.2017.08.02310.1016/j.bios.2017.08.023 ↗
39. 10.1016/j.bios.2017.07.06210.1016/j.bios.2017.07.062 ↗
40. 10.1016/j.jinorgbio.2015.06.02110.1016/j.jinorgbio.2015.06.021 ↗
41. 10.1016/j.jelechem.2015.07.01210.1016/j.jelechem.2015.07.012 ↗
42. 10.1016/j.talanta.2018.02.06310.1016/j.talanta.2018.02.063 ↗
43. 10.1016/j.jorganchem.2016.04.01710.1016/j.jorganchem.2016.04.017 ↗
44. 10.1038/s41598-017-11750-810.1038/s41598-017-11750-8 ↗
45. 10.1016/j.apsusc.2017.01.11010.1016/j.apsusc.2017.01.110 ↗
46. 10.1016/j.inoche.2012.05.02110.1016/j.inoche.2012.05.021 ↗
47. 10.1016/j.snb.2016.09.04910.1016/j.snb.2016.09.049 ↗
48. 10.1016/j.electacta.2018.02.13210.1016/j.electacta.2018.02.132 ↗
49. 10.1016/j.bios.2018.07.02910.1016/j.bios.2018.07.029 ↗
50. 10.1039/c7ta07911g10.1039/c7ta07911g ↗
51. 10.1039/c8ce01868e10.1039/c8ce01868e ↗
52. 10.1021/acs.analchem.7b0417510.1021/acs.analchem.7b04175 ↗
53. 10.1021/ma000791p10.1021/ma000791p ↗
54. 10.1016/j.jelechem.2007.09.03610.1016/j.jelechem.2007.09.036 ↗
55. 10.1021/ac300110n10.1021/ac300110n ↗
56. 10.1021/acs.analchem.6b0035710.1021/acs.analchem.6b00357 ↗
57. 10.1016/j.genrep.2016.12.01210.1016/j.genrep.2016.12.012 ↗